Variant report

Variant	nsv887848
Chromosome Location	chr7:26000137-26059739
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:30)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:30 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:25979383..25981909-chr7:26003195..26005485,2	MCF-7	breast:
2	chr7:26012088..26013995-chr7:26018916..26021896,2	MCF-7	breast:
3	chr7:26039507..26041159-chr7:26046905..26048859,2	MCF-7	breast:
4	chr7:26012088..26013995-chr7:26018916..26021896,2	MCF-7	breast:
5	chr7:25989577..25991180-chr7:26014942..26017299,2	K562	blood:
6	chr7:26040752..26042589-chr7:26209168..26210697,2	K562	blood:
7	chr7:26034062..26036742-chr7:26049058..26051711,2	K562	blood:
8	chr7:26024108..26025764-chr7:26238840..26240758,2	MCF-7	breast:
9	chr7:26044998..26045618-chr9:87815434..87816194,2	MCF-7	breast:
10	chr7:26035382..26036550-chr7:26101032..26101905,6	MCF-7	breast:
11	chr7:26017997..26020642-chr7:26020861..26022607,2	K562	blood:
12	chr7:25989287..25991159-chr7:26005525..26008414,2	MCF-7	breast:
13	chr7:26048553..26051389-chr7:26053656..26055381,2	K562	blood:
14	chr7:26044346..26047065-chr7:26096452..26098804,2	MCF-7	breast:
15	chr7:26052639..26055224-chr7:26239653..26241256,2	K562	blood:
16	chr7:25990219..25991822-chr7:25999068..26002038,2	K562	blood:
17	chr7:26049479..26051389-chr7:26053881..26055684,2	K562	blood:
18	chr7:26014155..26016824-chr7:26226230..26228691,2	K562	blood:
19	chr7:26034062..26036742-chr7:26049058..26051711,2	K562	blood:
20	chr7:25997382..25998890-chr7:26000494..26002817,2	K562	blood:
21	chr7:26048553..26051389-chr7:26053656..26055381,2	K562	blood:
22	chr7:26017997..26020642-chr7:26020861..26022607,2	K562	blood:
23	chr7:26039507..26041159-chr7:26046905..26048859,2	MCF-7	breast:
24	chr7:26035423..26036364-chr7:26100860..26101483,2	MCF-7	breast:
25	chr7:25990295..25993400-chr7:26020103..26023231,3	MCF-7	breast:
26	chr7:26049479..26051389-chr7:26053881..26055684,2	K562	blood:
27	chr7:26001248..26003021-chr7:26014968..26017941,2	K562	blood:
28	chr7:25933954..25935974-chr7:26016586..26018998,2	MCF-7	breast:
29	chr7:26001248..26003021-chr7:26014968..26017941,2	K562	blood:
30	chr7:25990548..25994647-chr7:26001939..26005377,4	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HNRNPA2B1-3	chr7:26059124-26059168	NONHSAT119612
2	lnc-HNRNPA2B1-3	chr7:26059124-26059168	NONHSAT119611

No data

Variant related genes	Relation type
ENSG00000122566	chromatin interactions
ENSG00000122565	chromatin interactions
ENSG00000199085	chromatin interactions

Extended variants
information (count: 1752 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:1752 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6946189	chr7:26000137-26000138	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs553805238	chr7:26000141-26000142	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs567302789	chr7:26000188-26000189	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs185164438	chr7:26000205-26000206	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs146663894	chr7:26000225-26000226	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs190449644	chr7:26000274-26000275	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs182029280	chr7:26000348-26000349	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs56182391	chr7:26000421-26000422	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs71521743	chr7:26000449-26000450	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs186359390	chr7:26000472-26000473	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs560611577	chr7:26000490-26000491	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs529320283	chr7:26000516-26000517	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs542632230	chr7:26000548-26000549	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs190021301	chr7:26000555-26000556	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs11771341	chr7:26000560-26000561	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs531806124	chr7:26000565-26000566	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs568678817	chr7:26000574-26000575	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs571419882	chr7:26000584-26000585	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs527481227	chr7:26000615-26000616	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs547756037	chr7:26000642-26000643	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs74485266	chr7:26000725-26000726	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs536273458	chr7:26000746-26000747	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs35915015	chr7:26000768-26000769	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs570877549	chr7:26000796-26000797	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs180838671	chr7:26000812-26000813	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs569751074	chr7:26000815-26000816	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs538308359	chr7:26000842-26000843	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs10272068	chr7:26000855-26000856	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs577856388	chr7:26000881-26000882	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs534109456	chr7:26000925-26000926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs71521744	chr7:26000958-26000959	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs186375432	chr7:26000961-26000962	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs570190439	chr7:26001000-26001001	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs73685520	chr7:26001037-26001038	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs562698807	chr7:26001095-26001096	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs576613649	chr7:26001111-26001112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs139229172	chr7:26001135-26001136	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs34058132	chr7:26001213-26001214	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs565369579	chr7:26001219-26001220	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs556548113	chr7:26001246-26001247	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs527518044	chr7:26001271-26001272	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs142554163	chr7:26001335-26001336	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs561258012	chr7:26001360-26001361	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs529915241	chr7:26001441-26001442	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs549762651	chr7:26001442-26001443	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs569265985	chr7:26001443-26001444	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs548916824	chr7:26001477-26001478	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs191247906	chr7:26001537-26001538	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs539038041	chr7:26001581-26001582	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs183533270	chr7:26001671-26001672	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Cancer	21637783	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16397240	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Glioblastoma multiforme	18628472	CNVD
Non-syndromic sensorineural hearing loss	22570644	CNVD
Cancer	21183584	CNVD
abnormal development	18461090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21785460	CNVD
Follicular lymphoma	20505157	CNVD
Williams-beuren syndrome	22470819	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Colorectal cancer	16774939	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	21645411	CNVD
Lung adenocarcinoma	17086460	CNVD
Colorectal cancer	19455253	CNVD
Lung cancer	17086460	CNVD
Breast cancer	18852474	CNVD
early-passage human iPS cells	21368824	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:257 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:25994600-26001400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
2	chr7:25999000-26002400	Weak transcription	Spleen	Spleen
3	chr7:25999200-26000200	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr7:25999200-26001800	Weak transcription	Pancreas	Pancrea
5	chr7:25999200-26004000	Weak transcription	Rectal Mucosa Donor 31	rectum
6	chr7:25999400-26002600	Weak transcription	Liver	Liver
7	chr7:25999600-26003400	Enhancers	GM12878-XiMat	blood
8	chr7:26000200-26000400	Enhancers	H9 Cell Line	embryonic stem cell
9	chr7:26001400-26001800	Enhancers	iPS-18 Cell Line	embryonic stem cell
10	chr7:26001800-26002800	Enhancers	Pancreas	Pancrea
11	chr7:26002400-26002800	Enhancers	Spleen	Spleen
12	chr7:26002600-26002800	Enhancers	Right Atrium	heart
13	chr7:26002600-26004000	Enhancers	Liver	Liver
14	chr7:26002800-26004000	Weak transcription	Pancreas	Pancrea
15	chr7:26002800-26007200	Weak transcription	Spleen	Spleen
16	chr7:26002800-26009000	Weak transcription	Right Atrium	heart
17	chr7:26003000-26003200	Enhancers	Fetal Muscle Trunk	muscle
18	chr7:26003200-26004800	Enhancers	Skeletal Muscle Male	skeletal muscle
19	chr7:26003400-26003600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
20	chr7:26003400-26005200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
21	chr7:26003400-26005600	Flanking Active TSS	GM12878-XiMat	blood
22	chr7:26003600-26004800	Enhancers	Skeletal Muscle Female	skeletal muscle
23	chr7:26003800-26004000	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr7:26003800-26005000	Enhancers	Rectal Mucosa Donor 29	rectum
25	chr7:26003800-26005600	Enhancers	Fetal Lung	lung
26	chr7:26004000-26004200	Enhancers	Duodenum Mucosa	Duodenum
27	chr7:26004000-26004200	Bivalent Enhancer	Left Ventricle	heart
28	chr7:26004000-26004800	Flanking Active TSS	Liver	Liver
29	chr7:26004000-26004800	Enhancers	Gastric	stomach
30	chr7:26004000-26005000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr7:26004000-26005000	Enhancers	Fetal Thymus	thymus
32	chr7:26004000-26005200	Enhancers	Pancreas	Pancrea
33	chr7:26004000-26005200	Enhancers	Rectal Mucosa Donor 31	rectum
34	chr7:26004200-26004400	Flanking Active TSS	Duodenum Mucosa	Duodenum
35	chr7:26004400-26004600	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
36	chr7:26004400-26005000	Bivalent Enhancer	Hela-S3	cervix
37	chr7:26004400-26005200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
38	chr7:26004400-26005200	Enhancers	Fetal Muscle Leg	muscle
39	chr7:26004600-26005000	Enhancers	Stomach Mucosa	stomach
40	chr7:26004600-26005000	Enhancers	NHEK	skin
41	chr7:26004600-26005200	Bivalent Enhancer	Duodenum Mucosa	Duodenum
42	chr7:26004800-26005000	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr7:26004800-26005000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
44	chr7:26004800-26005200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr7:26004800-26005400	Enhancers	Liver	Liver
46	chr7:26004800-26007200	Weak transcription	Gastric	stomach
47	chr7:26005000-26005200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr7:26005000-26005200	Enhancers	Hela-S3	cervix
49	chr7:26005000-26005600	Flanking Active TSS	NHEK	skin
50	chr7:26005000-26006200	Weak transcription	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links